Answers are grounded in this paper and cite their sources.
Lu-PSMA-617 and validated across a pooled analysis. Marked heterogeneity among individual HRR genes was observed, supporting gene-level rather than composite HRR analysis for precision oncology in radiopharmaceutical therapy.
No takes yet. Share an insight, caveat, or question.
Mahajan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: